The intestinal microbiota fuelling metabolic inflammation

Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury

Wang, Y., Liu, Y., Sidhu, A., Ma, Z., McClain, C. J., & Feng, W. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00024.2012 · Cited by 238

Muramyl Dipeptide-Based Postbiotics Mitigate Obesity-Induced Insulin Resistance via IRF4

Cavallari, J. F., Fullerton, M. D., Duggan, B. M., Foley, K. P., Denou, E., Smith, B. K., Desjardins, E. M., Henriksbo, B. D., Kim, K. J., Tuinema, B. R., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.03.021 · Cited by 237

Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus

Tang, W. H. W., Wang, Z., Li, X. S., Fan, Y., Li, D. S., Wu, Y., & Hazen, S. L. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.263640 · Cited by 234

Functional Gut Microbiota Remodeling Contributes to the Caloric Restriction-Induced Metabolic Improvements

Fabbiano, S., Suárez-Zamorano, N., Chevalier, C., Lazarević, V., Kieser, S., Rigo, D., Léo, S., Veyrat‐Durebex, C., Gaïa, N., Maresca, M., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.08.005 · Cited by 233

Weight-loss interventions and gut microbiota changes in overweight and obese patients: a systematic review

Seganfredo, F. B., Blume, C. A., Moehlecke, M., Giongo, A., Casagrande, D. S., Spolidoro, J. V. N., Padoin, A. V., Schaan, B. D., & Mottin, C. C. (2017) · Obesity Reviews · doi:10.1111/obr.12541 · Cited by 228

Microbiota Sensing by Mincle-Syk Axis in Dendritic Cells Regulates Interleukin-17 and -22 Production and Promotes Intestinal Barrier Integrity

Martínez-López, M., Iborra, S., Conde-Garrosa, R., Mastrangelo, A., Danne, C., Mann, E. R., Reid, D. M., Gaboriau-Routhiau, V., Chaparro, M., Lorenzo, M. P., et al. (2019) · Immunity · doi:10.1016/j.immuni.2018.12.020 · Cited by 228

Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats

Suzuki, T., & Hara, H. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-19 · Cited by 224

Blood Microbiota Dysbiosis Is Associated with the Onset of Cardiovascular Events in a Large General Population: The D.E.S.I.R. Study

Amar, J., Lange, C., Payros, G., Garret, C., Chabo, C., Lantieri, O., Courtney, M., Marre, M., Charles, M.-A. A., Balkau, B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054461 · Cited by 222

Association between microbiota-dependent metabolite trimethylamine-N-oxide and type 2 diabetes

Shan, Z., Sun, T., Huang, H., Chen, S., Chen, L., Luo, C., Yang, W., Yang, X., Yao, P., Cheng, J., et al. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.157107 · Cited by 210

Exercise Alleviates Obesity-Induced Metabolic Dysfunction via Enhancing FGF21 Sensitivity in Adipose Tissues

Geng, L., Liao, B., Jin, L., Huang, Z. P., Triggle, C. R., Ding, H., Zhang, J., Huang, Y., Lin, Z., & Xu, A. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.014 · Cited by 208

Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice

Ye, D., Li, F. Y. L., Lam, K. S. L., Li, H., Jia, W., Wang, Y., Man, K., Lo, C. M., Li, X., & Xu, A. (2012) · Gut · doi:10.1136/gutjnl-2011-300269 · Cited by 206

Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes

Genser, L., Aguanno, D., Soula, H. A., Dong, L., Barbot-Trystram, L., Assmann, K. E., Salem, J., Vaillant, J., Oppert, J., Laugerette, F., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5134 · Cited by 202

High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids

Stenman, L. K. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i9.923 · Cited by 201

Insulin resistance and C‐reactive protein as independent risk factors for non‐alcoholic fatty liver disease in non‐obese Asian men

Park, S. H., Kim, B. I., Yun, J. W., Kim, J. W., Park, D. I., Cho, Y. K., Sung, I. K., Park, C. Y., Sohn, C. I., Jeon, W. K., et al. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03362.x · Cited by 201

Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors

Teixeira, T. F. S., Souza, N. C., Chiarello, P. G., Franceschini, S. C. C., Bressan, J., Ferreira, C. L. D. L. F., & Pelúzio, M. D. C. G. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.02.009 · Cited by 200

Palmitic Acid Hydroxystearic Acids Activate GPR40, Which Is Involved in Their Beneficial Effects on Glucose Homeostasis

Syed, I., Lee, J., Moraes‐Vieira, P. M., Donaldson, C. J., Sontheimer-Phelps, A., Aryal, P., Wellenstein, K., Kolar, M. J., Nelson, A. T., Siegel, D. R., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.01.001 · Cited by 200

Defective NOD2 peptidoglycan sensing promotes diet‐induced inflammation, dysbiosis, and insulin resistance

Denou, E., Lolmède, K., Garidou, L., Pomié, C., Chabo, C., Lau, T. C., Fullerton, M. D., Nigro, G., Zakaroff‐Girard, A., Luche, É., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404169 · Cited by 197

Gut permeability is related to body weight, fatty liver disease, and insulin resistance in obese individuals undergoing weight reduction

Damms-Machado, A., Louis, S., Schnitzer, A., Volynets, V., Rings, A., Basrai, M., & Bischoff, S. C. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.131110 · Cited by 195

Orai1-Mediated Antimicrobial Secretion from Pancreatic Acini Shapes the Gut Microbiome and Regulates Gut Innate Immunity

Ahuja, M., Schwartz, D. M., Tandon, M., Son, A., Zeng, M., Swaim, W., Eckhaus, M., Hoffman, V., Cui, Y., Xiao, B., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.02.007 · Cited by 195

Detection of Increased Plasma Interleukin-6 Levels and Prevalence of Prevotella copri and Bacteroides vulgatus in the Feces of Type 2 Diabetes Patients

Leite, A. Z., Rodrigues, N. D. C., Gonzaga, M. I., Paiolo, J. C. C., de Souza, C. A., Stefanutto, N. A. V., Omori, W. P., Pinheiro, D. G., Brisotti, J. L., Matheucci, E., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01107 · Cited by 192

Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity

Giorgio, V., Miele, L., Principessa, L., Ferretti, F., Villa, M. P., Negro, V., Grieco, A., Alisi, A., & Nobili, V. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.02.010 · Cited by 188

Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time

Sellmann, C., Priebs, J., Landmann, M., Degen, C., Engstler, A. J., Jin, C. J., Gärttner, S., Spruss, A., Huber, O., & Bergheim, I. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.05.011 · Cited by 188

An Interleukin-23-Interleukin-22 Axis Regulates Intestinal Microbial Homeostasis to Protect from Diet-Induced Atherosclerosis

Fatkhullina, A. R., Peshkova, I. O., Dzutsev, A., Aghayev, T., McCulloch, J. A., Thovarai, V., Badger, J. H., Vats, R., Sundd, P., Tang, H., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.09.011 · Cited by 186

Jejunal T Cell Inflammation in Human Obesity Correlates with Decreased Enterocyte Insulin Signaling

Monteiro-Sepulveda, M., Touch, S., Mendes-Sá, C., André, S., Poitou, C., Allatif, O., Cotillard, A., Fohrer-Ting, H., Hubert, E.-L., Remark, R., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.020 · Cited by 170

Fatty Acid Synthase Modulates Intestinal Barrier Function through Palmitoylation of Mucin 2

Wei, X., YANG, Z. K., Rey, F. E., Ridaura, V. K., Davidson, N. O., Gordon, J. I., & Semenkovich, C. F. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2011.12.006 · Cited by 167

High Fat Diet Causes Depletion of Intestinal Eosinophils Associated with Intestinal Permeability

Johnson, A. M. F., Costanzo, A. E., Gareau, M. G., Armando, A. M., Quehenberger, O., Jameson, J., & Olefsky, J. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122195 · Cited by 164

Oral Supplementation with Non-Absorbable Antibiotics or Curcumin Attenuates Western Diet-Induced Atherosclerosis and Glucose Intolerance in LDLR−/− Mice – Role of Intestinal Permeability and Macrophage Activation

Ghosh, S. S., Bie, J., Wang, J., & Ghosh, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108577 · Cited by 162

Microbiome, trimethylamine N-oxide, and cardiometabolic disease

Tang, W. H. W., & Hazen, S. L. (2017) · Translational Research · doi:10.1016/j.trsl.2016.07.007 · Cited by 160

Molecular and Cellular Basis of Microflora-Host Interactions1,

Winkler, P., Ghadimi, D., Schrezenmeir, J., & Kraehenbühl, J.-P. (2007) · Journal of Nutrition · doi:10.1093/jn/137.3.756s · Cited by 158

Circulating microbiome in blood of different circulatory compartments

Schierwagen, R., Silva, M. C. A., Madsen, M. S. A., Kolbe, C. C., Meyer, C. H., Thomas, D., Uschner, F. E., Magdaleno, F., Jansen, C., Pohlmann, A., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-316227 · Cited by 157

The Gordian Knot of dysbiosis, obesity and NAFLD

Mehal, W. Z. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.146 · Cited by 156

Enteric Delivery of Regenerating Family Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in Mice With Colitis

Darnaud, M., Santos, A. D., Gonzalez, P., Augui, S., Lacoste, C., Desterke, C., Hertogh, G. D., Valentino, E., Braun, E. J., Zheng, J., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.11.003 · Cited by 152

Lymphotoxin regulates commensal responses to enable diet-induced obesity

Upadhyay, V., Poroyko, V. A., Kim, T.-J., Devkota, S., Fu, S., Liu, D., Tumanov, A. V., Koroleva, E. P., Deng, L., Nagler‐Anderson, C., et al. (2012) · Nature Immunology · doi:10.1038/ni.2403 · Cited by 145

The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis

Puri, P., Liangpunsakul, S., Christensen, J. E., Shah, V. H., Kamath, P. S., Gores, G. J., Walker, S., Comerford, M., Katz, B. P., Borst, A. J., et al. (2017) · Hepatology · doi:10.1002/hep.29623 · Cited by 128

C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients

Zimmermann, E., Anty, R., Tordjman, J., Verrijken, A., Gual, P., Tran, A., Iannelli, A., Gugenheim, J., Bédossa, P., Francque, S., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.12.017 · Cited by 123

A cytokine network involving IL-36γ, IL-23, and IL-22 promotes antimicrobial defense and recovery from intestinal barrier damage

Ngo, V. L., Abo, H., Maxim, E., Harusato, A., Geem, D., Contreras, O. M., Merlin, D., Gewirtz, A. T., Nusrat, A., & Denning, T. L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718902115 · Cited by 123

Why Innate Lymphoid Cells?

Kotas, M. E., & Locksley, R. M. (2018) · Immunity · doi:10.1016/j.immuni.2018.06.002 · Cited by 123

Metabolic endotoxemia directly increases the proliferation of adipocyte precursors at the onset of metabolic diseases through a CD14-dependent mechanism

Luche, É., Cousin, B., Garidou, L., Sérino, M., Waget, A., Barreau, C., André, M., Valet, P., Courtney, M., Casteilla, L., et al. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.06.005 · Cited by 115

Peptidoglycan from the gut microbiota governs the lifespan of circulating phagocytes at homeostasis

Hergott, C. A., Roche, A. M., Tamashiro, E., Clarke, T. B., Bailey, A., Laughlin, A. L., Bushman, F. D., & Weiser, J. N. (2016) · Blood · doi:10.1182/blood-2015-10-675173 · Cited by 115

Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans

Pihlajamäki, J., Kuulasmaa, T., Kamińska, D., Simonen, M., Kärjä, V. J., Grönlund, S., Käkelä, P., Pääkkönen, M. E., Kainulainen, S., Punnonen, K. R. A., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.005 · Cited by 109

Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal Inflammation

Aden, K., Rehman, A., Falk‐Paulsen, M., Sécher, T., Kuiper, J. W., Tran, F., Pfeuffer, S., Sheibani‐Tezerji, R., Breuer, A., Luzius, A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.054 · Cited by 107

Pilot study: alterations of intestinal microbiota in obese humans are not associated with colonic inflammation or disturbances of barrier function

Brignardello, J., Morales, P., Díaz-Bautista, E., Romero, J., Brunser, O., & Gotteland, M. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04475.x · Cited by 103

Systematic review assessing the effectiveness of dietary intervention on gut microbiota in adults with type 2 diabetes

Houghton, D., Hardy, T., Stewart, C. J., Errington, L., Day, C. P., Trenell, M. I., & Avery, L. (2018) · Diabetologia · doi:10.1007/s00125-018-4632-0 · Cited by 97

Significant positive association of endotoxemia with histological severity in 237 patients with non‐alcoholic fatty liver disease

Pang, J., Xu, W., Zhang, X., Wong, G. L., Chan, A. W. H., Chan, H., Tse, C., Shu, S. S., Choi, P. C., Chan, H. L., et al. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14119 · Cited by 91

Circulating NOD1 activators and hematopoietic NOD1 contribute to metabolic inflammation and insulin resistance

Chan, K. L., Tam, T. H., Boroumand, P., Prescott, D., Costford, S. R., Escalante, N. K., Fine, N., Tu, Y., Robertson, S. J., Prabaharan, D., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.027 · Cited by 88

Compartmentalized Antimicrobial Defenses in Response to Flagellin

Vijayan, A., Rumbo, M., Carnoy, C., & Sirard, J. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.10.008 · Cited by 85

Abnormal intestinal permeability to sugars in diabetes mellitus

Mooradian, A. D., Morley, J. E., Levine, A. S., Prigge, W. F., & Gebhard, R. L. (1986) · Diabetologia · doi:10.1007/bf00454879 · Cited by 81

Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis

Verbeek, J., Lannoo, M., Pirinen, E., Ryu, D., Spincemaille, P., Elst, I. V., Windmolders, P., Thevissen, K., Cammue, B. P. A., van Pelt, J. F., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-306748 · Cited by 79

Plasma concentration of trimethylamine-N-oxide and risk of gestational diabetes mellitus

Li, P., Zhong, C., Li, S., Sun, T., Huang, H., Chen, X., Zhu, Y., Hu, X., Peng, X., Zhang, X., et al. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy116 · Cited by 78

Ursodeoxycholic acid protects against intestinal barrier breakdown by promoting enterocyte migration via EGFR- and COX-2-dependent mechanisms

Golden, J. M., Escobar, O. H., Nguyen, M. V. L., Mallicote, M. U., Kavarian, P., Frey, M. R., & Gayer, C. P. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00354.2017 · Cited by 69

Intestinal Ralstonia pickettii augments glucose intolerance in obesity

Udayappan, S. D., Kovatcheva‐Datchary, P., Bakker, G. J., Havik, S. R., Herrema, H., Cani, P. D., Bouter, K. E. C., Belzer, C., Witjes, J. J., Vrieze, A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181693 · Cited by 68

Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis

Yuan, J., Baker, S. S., Liu, W., Alkhouri, R. H., Baker, R. D., Xie, J., Ji, G., & Zhu, L. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12510 · Cited by 64

The severity of non-alcoholic fatty liver disease correlates with high sensitivity C-reactive protein value and is independently associated with increased cardiovascular risk in healthy population

Chiang, C.-H., Huang, C., Chan, W., Chen, J., & Leu, H. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.09.003 · Cited by 64

Effect of total starvation and very low calorie diets on intestinal permeability in man

Elia, M., Gören, A., Behrens, R. H., Barber, R. W., & Neale, G. (1987) · Clinical Science · doi:10.1042/cs0730205 · Cited by 54

Probiotic carbohydrates reduce intestinal permeability and inflammation in metabolic diseases

Strowski, M. Z., & Wiedenmann, B. J. (2009) · Gut · doi:10.1136/gut.2009.179325 · Cited by 45

Amelioration of intestinal barrier dysfunction by berberine in the treatment of nonalcoholic fatty liver disease in rats

Li, Y., Zheng, J., Hu, Y., Hou, H., Hao, S., Liu, N., & Wang, Y. (2017) · Pharmacognosy Magazine · doi:10.4103/pm.pm_584_16 · Cited by 43

Increased intestinal permeability in pathogenesis and progress of nonalcoholic steatohepatitis in rats

Jin, X. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i11.1732 · Cited by 41

Impact of Bariatric Surgery on White Adipose Tissue Inflammation

Labrecque, J., Laforest, S., Michaud, A., Biertho, L. D., & Tchernof, A. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.12.003 · Cited by 40

Postprandial endotoxemia may influence the development of type 2 diabetes mellitus: From the CORDIOPREV study

Camargo, A., Jiménez-Lucena, R., Alcala-Diaz, J. F., Rangel-Zúñiga, O. A., García‐Carpintero, S., López-Moreno, J., Blanco-Rojo, R., Delgado‐Lista, J., Pérez‐Martínez, P., van Ommen, B., et al. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.03.016 · Cited by 38

Role of MAIT cells in the immunopathogenesis of inflammatory diseases: New players in old game

Kumar, V., & Ahmad, A. (2017) · International Reviews of Immunology · doi:10.1080/08830185.2017.1380199 · Cited by 36

A low dose lipid infusion is sufficient to induce insulin resistance and a pro-inflammatory response in human subjects

Liang, H., Lum, H., Alvarez, A. V., Garduño‐García, J. D. J., Daniel, B. J., & Musi, N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195810 · Cited by 33

Elevated IgG levels against specific bacterial antigens in obese patients with diabetes and in mice with diet-induced obesity and glucose intolerance

Mohammed, N., Tang, L., Jahangiri, A., de Villiers, W. J. S., & Eckhardt, E. R. M. (2012) · Metabolism · doi:10.1016/j.metabol.2012.02.007 · Cited by 32

Role of Natural Killer T Cells in the Development of Obesity and Insulin Resistance: Insights From Recent Progress

Satoh, M., & Iwabuchi, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01314 · Cited by 26

Characterization of nano bamboo charcoal drug delivery system for Eucommia ulmoides extract and its anticancer effect In vitro

Li, X., Zhaoyan, Z., Zhang, S., et al. (2017) · Pharmacognosy Magazine · doi:10.4103/pm.pm_256_16 · Cited by 24

Adipose tissue microbiota in humans: an open issue

Zulian, A., Cancello, R., Cesana, E., Rizzi, E., Consolandi, C., Severgnini, M., Panizzo, V., Blasio, A. M. D., Micheletto, G., & Invitti, C. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.111 · Cited by 23

Deficiency of lymphotoxin-α does not exacerbate high-fat diet-induced obesity but does enhance inflammation in mice

Pamir, N., McMillen, T. S., Edgel, K. A., Kim, F., & LeBoeuf, R. C. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00447.2011 · Cited by 17

The signposts and winding roads to immunity and inflammation

Kanneganti, T. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-018-0108-1 · Cited by 5

Interaction between microbiota and immunity in health and disease

Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Research · doi:10.1038/s41422-020-0332-7 · Cited by 3,947

Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach

Targher, G., Tilg, H., & Byrne, C. D. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00020-0 · Cited by 586

A Global View of the Interplay between Non-Alcoholic Fatty Liver Disease and Diabetes

Stefan, N., & Cusi, K. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00003-1 · Cited by 593

Hallmarks of Health

López-Otín, C., & Kroemer, G. (2021) · Cell · doi:10.1016/j.cell.2020.11.034 · Cited by 499

Gut microbiome, liver immunology, and liver diseases

Wang, R., Tang, R., Li, B., Ma, X., Schnabl, B., & Tilg, H. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00592-6 · Cited by 466

Effects of diet interventions on gut microbiota of nonalcoholic fatty liver disease

Di, H. (2017) · Int J Endocrinol Metab · doi:10.3760/cma.j.issn.1673-4157.2017.04.010

Prevalence of fatty liver in metabolic syndrome

Goyal, A., Arora, H., & Arora, S. (2020) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1108_19 · Cited by 17

Gut microbiota and nonalcoholic fatty liver disease

Kim, B., & Kim, B. K. (2023) · Kosin Medical Journal · doi:10.7180/kmj.23.138 · Cited by 2

Does Non-Alcoholic Fatty Liver Disease (NAFLD) Increase Cardiovascular Risk?

Montecucco, F., & Mach, F. (2008) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153008786848268 · Cited by 17

Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease

Cheng, Y.-L., Wang, Y., Lan, K., Huo, T., Huang, Y., Su, C., Hsieh, W.-Y., Hou, M., Lin, H., Lee, F., et al. (2017) · Gastroenterology Research and Practice · doi:10.1155/2017/9279836 · Cited by 27